Julie M Cunningham

23PUBLICATIONS
291CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cancer geneticsPredictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Mar 31, 2025
Evaluating cell type deconvolution in FFPE breast tissue: application to benign breast disease.

Yuanhang Liu, Robert A Vierkant, Aditya Bhagwate

|Feb 01, 2024
Risk Factors for Ovarian Cancer by BRCA Status: A Collaborative Case-Only Analysis.

Kate Gersekowski, Renhua Na, Kathryn Alsop

|Feb 15, 2023
Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma.

Chen Wang, Matthew S Block, Julie M Cunningham

|Dec 01, 2022
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer.

Dale W Garsed, Ahwan Pandey, Sian Fereday

|Nov 03, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study.

Ashley Weir, Eun-Young Kang, Nicola S Meagher

|Jul 11, 2022
Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes.

Kelly L Bolton, Denise Chen, Rosario Corona de la Fuente

Pageof 4

Frequent Collaborators

12 joint publications

Paul Pharoah

10 joint publications

Stacey J Winham

9 joint publications

James D Brenton

8 joint publications

Anna DeFazio